baber/WOPTO huggingface dataset:
Patent NZ-542322-A (NZ)
Title: Method and apparatus for generating standardized carbon emission reduction credits
Inventor: ZIMMERMAN PATRICK ROBERT
IPC: G06Q30/00
Filed: 2004-02-06
Abstract: An apparatus to generate a quantity of standardized carbon emission reduction credits, comprises an interface provided on an user node linked to a communications network adapted to receive data relevant to carbon sequestration from, and to disseminate information to, a potential producer of standardized carbon emission reduction credits; a data structure stored in memory accessible via the communications network adapted to receive and store data relevant to carbon sequestration in addition to the data received by the interface; and data processing means linked to a communications network adapted to receive data from the interface and data from the data structure to determine a change in the level of carbon compounds stored in a media, to conduct an uncertainty analysis. The uncertainty analysis includes determining an uncertainty in the determined approximate change in the level of carbon compounds and to identify a first quantity of standardized carbon emission reduction credits based on the determined uncertainty to set aside a number of carbon emission reduction credits that are identified as not being suited for trading due to the determined uncertainty.
Patent NZ-554787-A (NZ)
Title: Collagen producing plants and methods of generating and using same
Inventor: SHOSEYOV ODED
Filed: 2005-09-28
Abstract: Provided is a method of producing collagen or procollagen in a plant or an isolated plant cell comprising targeting to a vacuole of the plant or the isolated plant cell at least one type of a collagen chain and an exogenous prolyl-4-hydroxylase (P4H) so as to allow hydroxylation of said at least one type of said collagen chain by said exogenous P4H and not by an endogenous P4H of the plant or isolated plant cell, wherein each of said at least one type of collagen chain and said exogenous P4H comprise a signal peptide for targeting to said vacuole, thereby producing the collagen or procollagen in the plant. Further provided are accordingly genetically modified plants, nucleic acids encoding P4H attached to a vacuole targeting signal and positioned under the control of a promoter functional in plants.
Patent NZ-554951-A (NZ)
Title: Liposome formulation of peptide boronic acid compounds
Inventor: ZALIPSKY SAMUEL
IPC: A61K9/127
Filed: 2005-11-04
Abstract: Disclosed is a composition comprising liposomes formed of a vesicle-forming lipid and entrapped in said liposome is a boronate ester compound prepared from a peptide boronic acid compound and a polyol, with the proviso that the peptide boronic acid compound is not bortezomib.
Patent NZ-555124-A (NZ)
Title: Arylsulfonylmethyl or Arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine D3 receptor
Inventor: DRESCHER KARLA
IPC: A61K31/13
Filed: 2005-10-14
Abstract: Disclosed is an sulfonyl aromatic compound of the formula I wherein Ar is phenyl or an aromatic 5- or 6-membered C-bound heteroaromatic radical, X is N or CH; Y is O, S, -CH=N ,-CH=CH- or -N=CH-; A is CH2 , O or S; E is CR6R7 or NR3. R1 is alkyl, cycloalkyl, cycloalkylmethyl, alkenyl, fluorinated alkyl, fluorinated cycloalkyl, fluorinated cycloalkylmethyl, fluorinated alkenyl, formyl or alkylcarbonyl; R" is H, or R" and R2 together are (CH2)n with n being 2 or 3, or R1a and R2a together are (CH2)n with n being 2 or 3; R2 and R2a are independently of each other H, CH3, CH2F, CHF2 or CF3 and R3 - R7 are defined as in the specification and the physiologically tolerated acid addition salts thereof. Also disclosed is a composition comprising said compound and the use of said compound in the manufacture of a medicament for the treatment of a medical disorder susceptible with a dopamine D3 receptor ligand e.g. addiction.
Patent NZ-556369-A (NZ)
Title: Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
Inventor: LAZZARINI AMERIGA
IPC: C07K14/195
Filed: 2005-01-19
Abstract: Disclosed are antibiotics of formula (I) wherein X is selected from the group consisting of F, Cl, Br and I; and wherein R1-R8 are independently selected from H, OH, alkyl and aryl. Antibiotics of the type above have been isolated from a strain of Microbispora sp. ATCC PTA-5024 and are useful in the treatment of bacterial infections.
Patent NZ-560722-A (NZ)
Title: Immunostimulatory nucleic acids
Inventor: KRIEG ARTHUR M
IPC: A61K48/00
Filed: 2003-08-19
Abstract: Disclosed is an immunostimulatory oligonucleotide having at least two internal cytosineguanine (CG) dinucleotides and a chimeric backbone, wherein the at least two internal CG dinucleotides have a phosphodiester or phosphodiester-like internucleotide linkage and are separated by at least one stabilized internucleotide linkage, wherein optionally each additional internal CG dinucleotide has a phosphodiester, phosphodiester-like, or stabilized internucleotide linkage, and wherein all other internucleotide linkages are stabilized.
Patent NZ-567232-A (NZ)
Title: Body massager with a light source mounted on a massage formation
Inventor: FERBER ROMAN
IPC: A61H7/00
Filed: 2006-08-10
Abstract: Disclosed is a massage apparatus with illumination effects. The apparatus includes a housing (46); a massage formation (136') provided on the housing for contacting a body part of a user; a massage mechanism oriented within the housing for imparting a massage effect to the massage formation for massaging the body part; and a light source (146) provided on the massage formation for conveying an illumination effect from the massage formation. The apparatus further includes: a carriage (52) oriented in the housing for limited translation in the housing, the massage formation provided on the carriage; a motor supported upon the carriage; and a shaft (110) mounted on the carriage and operably driven by the motor for rotation about an axis. The shaft has a pair of secondary shaft portions each canted relative to the shaft axis. The apparatus also has: a pair of massage brackets (124) each joumalled to one of the secondary shaft portions and engaging the carriage for limited rotation about the shaft axis such that rotation of the shaft oscillates the massage brackets relative to the carriage; a pair of massage arms (136') each pivotally connected to one of the massage brackets; and a pair of massage rollers (138', 140') each pivotally connected to one of the massage arms. The massage rollers impart a rolling massage effect upon a desired body part of the user as the carriage is translated relative to the housing and for imparts a kneading massage effect upon the portion of the user's body as the massage brackets oscillate relative to the carriage.
Patent NZ-568422-A (NZ)
Title: Bicyclic cinnamide compound
Inventor: KIMURA TEIJI
IPC: A61K31/4178
Filed: 2006-11-01
Abstract: Disclosed is a bicyclic hexahydroindolizin-5-one compound represented by the formula (I) or a pharmacologically acceptable salt thereof, wherein the substituents are defined in the specification. Also disclosed is a composition comprising said compound and the use of said compound in the production of a medicament for the treatment of a disease caused by amyloid-beta e.g. senile dementia.
Patent NZ-570371-A (NZ)
Title: Order-taking system with wireless and internet-based communication and remote monitoring
Inventor: AWISZUS STEVEN T
IPC: G06Q30/00
Filed: 2007-02-01
Abstract: An order-taking system (10) for an establishment (12) enabling a customer to place an order for an item from the establishment (12) comprising order-placing equipment (14) located near the establishment (12) for receiving the customer's order, a local order-receiving facility (20a, 20b. 20n) and a remote order-receiving facility (24). Communication links (22, 28) are provided both between the local order-receiving facility (20a, 20b. 20n) and the order-placing equipment (14) and between the remote order-receiving facility (24) and the order-placing equipment (14). The system (10) is able to operate in two modes; in one mode the local order-receiving facility (20a, 20b. 20n) has primary order-taking responsibility and communicates with the order-placing equipment (14) via their shared communication link (22) while these communications are monitored by the remote order-receiving facility (24); in the other mode the remote order-receiving facility (24) has primary order-taking responsibility and communicates with the order-placing equipment (14) via their shared communication link (28) while these communications are monitored by the local order-receiving facility (20a, 20b. 20n). An alarm may also be provided to indicate a change in order-taking responsibility.
Patent NZ-572304-A (NZ)
Title: Injection of subsurface soil fumigant at discrete sites
Inventor: ALLAN MICHAEL A
IPC: G01S19/14
Filed: 2007-03-13
Abstract: An apparatus for injecting discrete predetermined amounts of material, such as the fumigant iodomethane, at a plurality of predetermined points into the soil includes a container of the material connected by at least one tube 209 to at least one electrically controlled injector 212 which is detachably mounted to an injector mounting element 203 at the base 202 of a soil penetrating shank. As the shank is drawn through the soil a controller activates the electrically controlled injector to inject a predetermined amount of the material into the soil at predetermined points in the soil.
Patent NZ-585997-A (NZ)
Title: Method of producing egg yolk based functional food product and products obtainable thereby
Inventor: THIELEN WILHELMUS JOHANNES GERTRUDES
IPC: A23L15/00
Filed: 2008-12-17
Abstract: Disclosed herein is a method for increasing the efficiency of the absorption of xanthophylls from a food product in the gastro-intestinal tract wherein the food product is to be eaten by a human or an animal, and wherein the food product comprises a mixture of an aqueous dispersion and said xanthophylls contained in egg yolk, wherein the egg yolk and the aqueous dispersion are present in the food product in a ratio between 1:2 respectively and 1:7 respectively, or a dried equivalent thereof; and wherein the food product affords high biological availability of said xanthophylls once eaten. Also disclosed is the use of a composition comprising a mixture of an aqueous dispersion and xanthophylls contained in egg yolk, wherein the egg yolk and the aqueous dispersion (preferably the aqueous dispersion is selected from the group consisting of skimmed milk, semi-skimmed milk, buttermilk fermented milk, such as yoghurt, soy drink, soy milk, fermented soy milk, fruit juices, fruit purees, syrups, vegetable juices and vegetable purees) are present in a ratio of 1:2 to 1:7 respectively, or the dried equivalent thereof, in the manufacture of a medicament for the treatment of atherosclerosis, cataract, to reduce the incidence and/or severity of age-related macular degeneration and/or for improving skin health.
Patent NZ-591667-A (NZ)
Title: A heparan sulphate which binds bmp2
Inventor: COOL SIMON MCKENZIE
IPC: A61K35/12
Filed: 2009-09-11
Abstract: Provided is isolated or substantially purified heparan sulphate HS/BMP2, wherein following digestion with heparinase, heparitinase I and heparitinase II to completion and then subjecting the resulting disaccharide fragments to strong anion exchange HPLC (SAX-HPLC) the heparan sulphate HS/BMP2 has a disaccharide composition comprising: UA-GlcN 8.2% (±3%); UA-GlcNAc 17.5% (±3%); UA-GlcN,6S 3.7% (±3%); UA,2S-GlcN 4.5% (±3%); UA-GlcNS 16.2% (±3%) UA-GlcNAc,6S 0% (±3%) UA,2S-GlcNAc 0% (±3%) UA,2S-GlcN,6S 0% (±3%) UA-GlcNS,6S 0% (±3%) UA,2S-GlcNS 0% (±3%) UA,2S-GlcNAc,6S 0% (±3%) UA,2S-GlcNS,6S 0.5% (±3%). The compositions can be used to treat wound healing, bone regeneration and growing connective tissue in vitro.
Patent NZ-594212-A (NZ)
Title: Method for production of lactoferrin
Inventor: PERRAUDIN JEAN-PAUL
IPC: A61K38/00
Filed: 2010-01-28
Abstract: Disclosed is Lactoferrin having more than 95% purity, substantially free of LPS, endotoxins and angiogenin with an iron saturation level comprised between 9%-20%. Also disclosed is a method for the production of said lactoferrin. The method comprising at least the steps of: disposing of raw material selected in the group consisting of skimmed milk before the pasteurization, caseinate-free milk, cheese-whey or skimmed colostrum that has not been treated at a temperature greater than 50 degrees Celsius; submitting this raw material to a treatment in order to obtain a solution of lactenin (LN) or Milk Basic Protein (MBP); submitting the LN or MBP solution to a purification step on a cation exchange resin equilibrated with an acetate buffer at a pH between 4 and 9 and eluted with different buffer solutions containing different solute concentrations; and collecting a fraction containing lactoferrin having more than 95% of purity, having no polymers and substantially free of LPS, endotoxins and angiogenin.
Patent NZ-598694-A (NZ)
Title: Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
Inventor: GILBERT ERIC J
IPC: A61K31/54
Filed: 2010-10-06
Abstract: 598694 The present disclosure provides certain iminothiadiazine dioxide compounds, including compounds Formula 25, 26, 34, 35, 36, 40di, 40ai, 40cd, 123 and 173. The iminothiadiazine dioxide compounds of the disclosure have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to Beta-amyloid (Aβ) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (A-Beta) protein, including Alzheimers disease, are also disclosed
Patent NZ-599523-A (NZ)
Title: Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
IPC: A61K47/48
Filed: 2008-04-30
Abstract: Abstract - 599523 Disclosed herein is a drug-loaded micelle comprising a multiblock copolymer of formula III, wherein the substituents are as defined within the specification, preferably the drug is chosen from SN-38, doxorubicin or docetaxel.
Patent NZ-600161-A (NZ)
Title: Novel tricyclic compounds
Inventor: STEWART KENT D
IPC: A01N43/58
Filed: 2010-12-01
Abstract: The disclosure provides compounds of Formula (I) and Formula (II), pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the disclosure are useful for treating immunological and oncological conditions. In one embodiment the compound is 3-((3S,4S)-3-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-4-methylpiperidin-1-yl)-3-oxopropanenitrile.
Patent NZ-602758-A (NZ)
Title: Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
Inventor: OKHAMAFE AUGUSTUS
IPC: A61K31/496
Filed: 2006-05-23
Abstract: Disclosed are crystalline or amorphous forms of a lactic acid salt of 4-amino-5-fluoro-3-[6-(4-methylpiperzin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one (Formula I), and solvates and hydrates thereof. The compound of formula I is a protein kinase inhibitor and is useful in the treatment of cancer.
Patent NZ-610854-A (NZ)
Title: An alignment device
Inventor: RAFFERTY CHRISTOPHER CHARLES
IPC: E04G17/14
Filed: 2011-11-21
Abstract: An alignment device (10) able to align substantially vertical starter bars (5) for a masonry block wall is disclosed. The alignment device (10) comprises a plurality of spacer arms (20), a plurality of attachment members (30) and one or more adjustable supports (50). The spacer arms (20) are spaced at a predetermined distance from each other. The attachment members (30) are attached to respective spacer arm (20) and are capable of being operatively attached to the vertical starter bars (5). The adjustable supports (50) operatively support the spacer arms (20) at a desired position.
Patent NZ-612231-A (NZ)
Title: Control system for a refrigerated merchandiser
Inventor: STREET NORMAN E
IPC: G05B19/04
Filed: 2013-06-20
Abstract: 612231 A method of controlling a refrigerated merchandiser (45) to prevent ignition of any leaking refrigerant is disclosed. The method includes refrigerating a product display area (65) of the merchandiser using a refrigerant, detecting (160) a presence of an air-refrigerant mixture in the refrigerated merchandiser, activating a fan (145) in response to detecting the presence of an air-refrigerant mixture, and at least partially evacuating an interior of the merchandiser in response to fan activation. A refrigerated merchandiser is also disclosed.
Patent NZ-613436-A (NZ)
Title: Aqueous wax emulsions having reduced solids content for use in gypsum compositions and building products
Inventor: STUART JONATHAN T
IPC: C04B40/00
Filed: 2011-10-20
Abstract: Aqueous wax emulsions are disclosed herein for use in gypsum formulations for making weatherboards and other building products, wherein the emulsions comprises water; a paraffinic hydrocarbon; a montan wax component; and a hydrocarbon component preferably selected from aromatic petroleum hydrocarbon resin, terpene resins, terpene phenolic resins, rosin, rosin esters, pentaerthyritol-containing rosins, pentaerythritol-containing, coumarone-indene resins, alkyl-, alkenyl-, alkynl-, or aryl-functionalized naphthalene esters etc. The aqueous wax emulsions contain lower solids content and more water, reducing costs of materials while maintaining viscosity properties and reducing drying energy time; both lowering manufacturing costs. The resin has a molecular weight (MW) of no greater than about 3,000, wherein the hydrocarbon component has a softening point of from about 22 °C to about 110 °C. Methods of making such emulsions are also provided.
Patent NZ-615710-A (NZ)
Title: Antagonists of the interleukin- 1 receptor
Inventor: BEREZIN VLADIMIR
IPC: C12N15/24
Filed: 2012-03-14
Abstract: Disclosed is a peptide consisting of a peptide sequence of 7 to 14 contiguous amino acid residues derived from IL-1 receptor antagonist protein (IL1RA), said peptide comprising the amino acid sequence of SEQ ID NO: 1 (SGRKSSKMQA), or consisting of a fragment of 7 to 9 consecutive amino acids of SEQ ID NO:1, or comprising a variant of SEQ ID NO:1 having at least 75% sequence identity to SEQ ID NO:1, or consisting of a variant of a fragment of SEQ ID NO:1, said variant consisting of an amino acid sequence of 7 to 9 consecutive amino acids of SEQ ID NO:1 having at least 75% sequence identity to any one of SEQ ID NO:1, wherein said peptide binds to IL-1 receptor type 1 (IL1RI), and interferes with the binding of IL-1 beta to IL1RI.
Patent NZ-622261-A (NZ)
Title: Method of creating and maintaining multi-manager exchange traded funds
Inventor: ROBERTS MARK STADLER
IPC: G06Q40/04
Filed: 2012-09-19
Abstract: Disclosed is systems and methods for creating and maintaining multi-manager exchange traded funds. An embodiment of a method includes receiving a plurality of model portfolios, each created by a different portfolio manager and identifying a plurality of assets traded on a stock exchange. A portfolio composition file is created based at least in part on at least a portion of the model portfolios. The portfolio composition file identifies a set of constituent assets traded on the stock exchange. One or more authorized participants are authorized to trade the set of constituent assets for a creation unit of an exchange traded fund. The creation unit includes at least one share that is tradable on the stock exchange by both the authorized participant(s) and the investors. The portfolio composition file is transmitted to a plurality of authorised participants on a first trading day or a second trading day immediately following the first trading day.
Patent NZ-627559-A (NZ)
Title: Inhibitors of notch signalling pathway and use thereof in treatment of cancers
Inventor: RADTKE FREDDY
IPC: A61P35/00
Filed: 2012-12-21
Abstract: The present disclosure relates to compounds of formulae II, III and IV where the substituents are as defined herein as inhibitors of Notch signalling pathway in treating and/or preventing cancers, wherein the Notch dependent cancer is selected from the group comprising T cell-Acute lymphoblastic leukemia (T-ALL), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), Mantle cell lymphoma (MCL), breast cancer, pancreatic cancer, prostate cancer, melanoma, brain tumors, tumor angiogenesis, and colorectal cancer. An example is the compound is: 6-(4-tert-butylphenoxy)pyridin-3-amine.
Patent NZ-628463-A (NZ)
Title: Ratio based biomarkers and methods for use thereof
Inventor: HEWITT STEPHEN M
IPC: G01N33/574
Filed: 2010-01-13
Abstract: Disclosed is a method of determining cancer prognosis for a subject with a cancer, comprising: i) identifying at least two cancer associated proteins in a sample from the subject, wherein the at least two cancer associated proteins comprise p-mTOR and PTEN, but not p-AKT, p-MAPK, or EGFR; ii) quantifying the at least two cancer associated proteins in the sample; iii) normalising the at least two cancer associated proteins in the sample to obtain a normalised value for each cancer associated protein in the sample; iv) comparing the normalised value of the first cancer associated protein with the normalised value of the second cancer associated protein to obtain a biomarker indicator that comprises a ratio of the normalized value of the first cancer associated protein to the normalized value of the second cancer associated protein; and v) correlating the biomarker indicator with prognosis of the subject with cancer.
Patent NZ-628601-A (NZ)
Title: Reaction platform and method for making pollen based materials in combination with beeswax and uses thereof
Inventor: IONA ELIZABETH WEIR
IPC: A61Q19/00
Filed: 2014-08-12
Abstract: Disclosed is a process for making a fermented pollen-based composition comprising the soaking of dry pollen grains in coconut water; treating the soaked pollen with glycerol and honeydew; adding beeswax; and incubating at 37 °C for 72 hours to give the desired composition. The process can also include the additional step of adding an enzyme component selected from the group consisting of pineapple powder, tamarillo powder, kawa kawa powder, kiwifruit powder, honey, or additional honeydew, and the additional step of adding propolis or pine bark powder to stop fermentation. The fermented pollen-based compositions are useful for treating skin conditions, particularly in the form of a topical skin cream composition.
Patent NZ-628627-A (NZ)
Title: Substituted chroman compounds as calcium sensing receptor modulators
Inventor: SHUKLA MANOJKUMAR RAMPRASAD
IPC: C07D311/58
Filed: 2013-02-22
Abstract: Disclosed herein are calcium sensing receptor modulators (CaSR) of formula I where the substituents are as defined herein. In particular, the compounds described herein are useful for treating, managing, and/or lessening the severity of diseases, disorders, syndromes and/or conditions associated with the modulation of calcium sensing receptors (CaSR). The invention also provides herein the pharmaceutical compositions thereof, and methods for treating, managing, and/or lessening the severity of diseases, disorders, syndromes and/or conditions associated with the modulation of CaSR. The invention also relates to process for the preparation of the compounds of the invention. The compounds of formula I include for example methyl 2-fluoro-5-((2R,4R)-2-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)chroman-4-yl)benzoate and methyl 5-((2R)-2-((((R)-1-(4-fluoro-3-methoxyphenyl)ethyl)amino)methyl)chroman-4-yl)-2-methylbenzoate. Also disclosed is the process for preparing a compound of formula I.